Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Inflammatory Bowel Diseases

  Free Subscription


1 Aliment Pharmacol Ther
1 Clin Gastroenterol Hepatol
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gut
4 Inflamm Bowel Dis
1 J Crohns Colitis
1 J Gastroenterol
1 Lancet Gastroenterol Hepatol
1 Mediators Inflamm
2 Scand J Gastroenterol
1 Z Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Aliment Pharmacol Ther

  1. DONG C, Metzger M, Holsbo E, Perduca V, et al
    Systematic review with meta-analysis: mortality in acute severe ulcerative colitis.
    Aliment Pharmacol Ther. 2019 Dec 10. doi: 10.1111/apt.15592.
    PubMed     Text format     Abstract available

    Clin Gastroenterol Hepatol

  2. ADEDOKUN OJ, Xu Z, Marano C, O'Brien C, et al
    Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis: Ustekinumab PK and exposure-response in UC.
    Clin Gastroenterol Hepatol. 2019 Dec 6. pii: S1542-3565(19)31403.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  3. GUBATAN J, Triadafilopoulos G, Fernandez-Becker NQ
    Double Threat: Interplay of Celiac Disease with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Dec 11. pii: 10.1007/s10620-019-05994.
    PubMed     Text format    

    Eur J Gastroenterol Hepatol

  4. SCHOEPFER A, Vavricka SR, Brungger B, Blozik E, et al
    Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.
    Eur J Gastroenterol Hepatol. 2019 Dec 9. doi: 10.1097/MEG.0000000000001616.
    PubMed     Text format     Abstract available


  5. CHA JM, Park SH, Rhee KH, Hong SN, et al
    Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
    Gut. 2019 Dec 10. pii: gutjnl-2019-319699. doi: 10.1136/gutjnl-2019-319699.
    PubMed     Text format     Abstract available

    Inflamm Bowel Dis

  6. TARIQ R, Disbrow MB, Dibaise JK, Orenstein R, et al
    Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 9. pii: 5673067. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. CHEN LA
    Intestinal Microbiota Transplantation for Patients With Inflammatory Bowel Disease Prevents Recurrence of C. difficile Infections but Not Recurrence of Gastrointestinal Symptoms.
    Inflamm Bowel Dis. 2019 Dec 10. pii: 5673070. doi: 10.1093.
    PubMed     Text format    

  8. KUENZIG ME, Hawken S, Wilson K, Talarico R, et al
    Serum Newborn Screening Blood Metabolites Are not Associated With Childhood-onset Inflammatory Bowel Disease: A Population-based Matched Case-control Study.
    Inflamm Bowel Dis. 2019 Dec 12. pii: 5674034. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. OUAHED J, Spencer E, Kotlarz D, Shouval DS, et al
    Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5675340. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Crohns Colitis

  10. MARK-CHRISTENSEN A, Erichsen R, Veres K, Laurberg S, et al
    Extracolonic cancer risk after total colectomy for inflammatory bowel disease: A population-based cohort study.
    J Crohns Colitis. 2019 Dec 7. pii: 5666210. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Gastroenterol

  11. NAGANUMA M, Yokoyama Y, Motoya S, Watanabe K, et al
    Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.
    J Gastroenterol. 2019 Dec 6. pii: 10.1007/s00535-019-01651.
    PubMed     Text format     Abstract available

    Lancet Gastroenterol Hepatol

  12. CHAPMAN TP, Gomes CF, Louis E, Colombel JF, et al
    De-escalation of immunomodulator and biological therapy in inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2020;5:63-79.
    PubMed     Text format     Abstract available

    Mediators Inflamm

  13. SHU W, Pang Z, Xu C, Lin J, et al
    Anti-TNF-alpha Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:4038619.
    PubMed     Text format     Abstract available

    Scand J Gastroenterol

  14. PIGNICZKI D, Rutka M, Farkas K, Molnar T, et al
    Lupus-like reactions in patients with inflammatory bowel disease: a little bit different data from another center.
    Scand J Gastroenterol. 2019 Dec 9:1. doi: 10.1080/00365521.2019.1690038.
    PubMed     Text format    

  15. RYHLANDER J, Ringstrom G, Simren M, Stotzer PO, et al
    Undergoing repeated colonoscopies - experiences from patients with inflammatory bowel disease.
    Scand J Gastroenterol. 2019 Dec 9:1-6. doi: 10.1080/00365521.2019.1698649.
    PubMed     Text format     Abstract available

    Z Gastroenterol

  16. HELWIG U
    [Appendicectomy prior to colectomy in ulcerative colitis?]
    Z Gastroenterol. 2019;57:1514.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.